from april 7-9, 2021, 5 weeks after the j&j/janssen covid-19 vaccine was authorized by fda for emergency use, clusters of anxiety-related events after janssen vaccination were reported to cdc. the review shows that u.s. cases of cvst and thrombocytopenia after j&j/janssen vaccination were clinically similar to cvst cases in europe after oxford/astrazeneca covid-19 vaccination. postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: reports to the vaccine adverse event reporting systemexternal icon. during that time, over 1.6 million vaccine recipients enrolled in v-safe, and vaers received 6,994 reports of adverse events following vaccination. myopericarditis after vaccination, vaccine adverse event reporting system (vaers), 1990-2018.external icon vaccine. moro pl, marquez p. reports of cell-based influenza vaccine administered during pregnancy in the vaccine adverse event reporting system (vaers), 2013-2020external icon. miller er, mcneil mm, moro pl, duffy j, su jr. the reporting sensitivity of the vaccine adverse event reporting system (vaers) for anaphylaxis and for guillain-barré syndrome.external icon vaccine. moro pl, woo el, marquez p, cano m. monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (vaers), 2011-2019.external icon vaccine. researchers searched the vaccine adverse event reporting system (vaers) for reports of adverse events (aes) following flu vaccination in infants less than 6 months old from 2010-2018. a total of 114 reports were found; 21 reported a specific ae. using the vaccine adverse event reporting system (vaers), researchers analyzed reports of adverse events (aes) following tdap in adults 65 years and older. researchers analyzed reports of adverse events (aes) after 9vhpv to the vaccine adverse event reporting system (vaers) from december 2014 to december 2017. during that time, approximately 28 million 9vhpv doses were distributed in the united states. the vaccine was first routinely given to recruits in october 2011. researchers reviewed reports of adverse events (aes) following the adenovirus vaccine from october 2011 to july 2018 using the vaccine adverse event reporting system (vaers). in a 25-year review of data from the vaccine adverse event reporting system, reports in children most commonly followed childhood vaccinations, and in adults most often followed influenza vaccine. excess doses of vaccine reported to the vaccine adverse event reporting system (vaers), 2007-2017.external icon vaccine. during 1990–2016, the vaccine adverse event reporting system (vaers) received a total of 467,960 reports. safety of 9-valent human papillomavirus vaccine administration among pregnant women: adverse event reports in the vaccine adverse event reporting system (vaers), 2014-2017external icon. in this review, reports submitted to the vaccine adverse event reporting systems (vaers) following 2vhpv vaccination during 2009-2017 were analyzed. diphtheria, tetanus toxoids and acellular pertussis (dtap) vaccines were first licensed by the food and drug administration in 1991. to assess the post-licensure safety of dtap vaccines, researchers reviewed reports of adverse events following vaccination submitted to the vaccine adverse event reporting system (vaers).
miller er, lewis p, shimabukuro tt, su j, moro p, woo ej, jankosky c, cano m. post-licensure safety surveillance of zoster vaccine live (zostavax®) in the united states, vaccine adverse event reporting system (vaers), 2006-2015externalexternal icon. post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the vaccine adverse event reporting system (vaers), 2009-2015externalexternal icon. safety of vaccines that have been kept outside of recommended temperatures: reports to the vaccine adverse event reporting system (vaers), 2008-2012.external icon vaccine. safety of vaccines that have been kept outside of recommended temperatures: reports to the vaccine adverse event reporting system (vaers), 2008-2012external icon. moro p, baumblatt j, lewis p, cragan j, tepper n, cano m. surveillance of adverse events after seasonal influenza vaccination in pregnant women and their infants in the vaccine adverse event reporting system, july 2010-may 2016.external icon drug saf. post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the vaccine adverse event reporting system (vaers), 1990-2013.external icon vaccine. preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the us vaccine adverse event reporting system, 2000-2012external icon. safety of quadrivalent human papillomavirus vaccine (gardasil®) in pregnancy: adverse events among non-manufacturer reports in the vaccine adverse event reporting system, 2006-2013external icon. 2014 aug 20;32(37):4758-65. moro pl, museru oi, niu m, lewis p, broder k. reports to the vaccine adverse event reporting system after hepatitis a and hepatitis ab vaccines in pregnant womenexternal icon. adverse events after fluzone® intradermal vaccine reported to the vaccine adverse event reporting system (vaers), 2011-2013external icon. adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the vaccine adverse event reporting system, 1990-2009external icon. adverse events following trivalent inactivated influenza vaccination in children: analysis of the vaccine adverse event reporting systemexternal icon. adverse events after anthrax vaccination reported to the vaccine adverse event reporting system (vaers), 1990-2007external icon. safety of varicella vaccine after licensure in the united states: experience from reports to the vaccine adverse event reporting system, 1995-2005external icon. vaccination of yeast sensitive individuals: review of safety data in the us vaccine adverse event reporting system (vaers)external icon. polyarteritis nodosa reports to the vaccine adverse event reporting system (vaers): implications for assessment of suspected vaccine-provoked vasculitisexternal icon. the role of the vaccine adverse event reporting system (vaers) in monitoring vaccine safetyexternal icon. infant immunization with acellular pertussis vaccines in the united states: assessment of the first two years’ data from the vaccine adverse event reporting system (vaers)external icon. adverse events after japanese encephalitis vaccination: review of post-marketing surveillance data from japan and the united statesexternal icon.
vaers is not designed to detect if a vaccine caused an adverse event, but it can identify unusual or unexpected patterns of reporting that might indicate possible safety problems requiring a closer look. patients, parents, caregivers and healthcare providers (hcp) are encouraged to report adverse events after vaccination to vaers even if it is not clear that the vaccine caused the adverse event. report the adverse event even if you are not sure if it was a result of vaccination. if you have your vaers identification number, you can access a copy of your report at the cdc vaers wonder website.
one of the main limitations of vaers data is that it cannot determine if the vaccine caused the reported adverse event. vaers accepts all reports of adverse health events following vaccinations without judging whether the vaccine caused the adverse health event. vaers accepts reports of adverse events following vaccination without judging the cause or seriousness of the event. reporting an adverse event to vaers does not constitute filing a claim with the vicp. vaers is co-sponsored by the centers for disease control and prevention (cdc), and the food and drug administration (fda), agencies of the u.s. department of health and human services (hhs).
rare instances of adverse events following covid-19 vaccinations have been reported to the vaccine adverse event reporting system. to search articles on this page by keyword, first click the “open all” tab to list all publications. then use the “find on this page” function available in healthcare providers who administer covid-19 vaccines are required by law to report to vaers the following after vaccination: vaccine administration errors,, .
is it true that vaers says 3000 people have died from the covid-19 vaccines? cdc is now using vaers data to probe whether covid-19 vaccines might rarely be causing heart inflammation in children; it has not yet reached a conclusion. one you might have seen the headlines on social media. “covid-19 vaccine-related fatalities exceed 6,000.” “6,000% increase in reported vaccine deaths 1st quarter, .
When you try to get related information on vaccine deaths vaers, you may look for related areas. .